ERBB2 and breast carcinoma: The expression of TERT in breast cancer cells may be subject to direct or indirect modulation by various signaling pathways, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), leading to differential manifestations of disease within the same subtype of breast cancer.